This past week, Google had its annual developers conference, Google I/O. One of the more provocative talks, called “The End of Search as We Know It,” was by Amit Singhal, who is in charge of search for Google.
The vision, as described by Amit, is that instead of typing words into a box on a website or mobile app, we will have conversations with Google, enabling a much more personalized, refined experience. The holy grail, of course, is that Google analytics become both predictive and prescriptive, serving you content that is just right for you and anticipates your needs.
It seems there is a race on now to achieve this vision. One could argue that Amazon, Apple, Facebook, Pandora and others are all in the same mode. Best I can tell, the promise these companies are floating to advertisers is that their ads will be served up to that focused slice of the population that will find their product relevant in the moment.
If you apply this thinking to healthcare, several controversies/topics come to the fore.
Is Google competing with IBM’s Watson? Undoubtedly yes. On the other hand, I’m guessing Google is disenchanted with the consumer health space after the demise of its personal health record (PHR). And IBM seems to be focused on clinician decision support. So early in the game, with respect to healthcare anyway, maybe there is not much competition. The path for clinician decision support is clear and the market obvious, whereas the path and market for consumer health decision support are blurry.
To achieve their vision of having a conversation with you at the level of search, Google has to know lots and lots about you. Some people are spooked by what they track now. Will there be a way for them to track all of the other necessary data points without running afoul of the privacy lobby?
Can we achieve the same vision for consumer health information (i.e., make it highly personalized, motivational, caring, and eerily anticipatory)?
At the Center for Connected Health, we are banking on it. A big part of our research agenda for the next several years will be in this area. Current work in type 2 diabetes and cancer pain control represent a start in this area.
Perhaps the most penetrating question is whether there is an economic imperative for personalized prevention that is as compelling as the one for personalized search. We know the economics of advertising and the ultimate goal of targeting every ad to someone who is a qualified, interested customer – someone who really views the product as a solution to their problem.